755 related articles for article (PubMed ID: 32355831)
1. Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival.
Geng Y; Guan R; Hong W; Huang B; Liu P; Guo X; Hu S; Yu M; Hou B
Ann Transl Med; 2020 Mar; 8(6):387. PubMed ID: 32355831
[TBL] [Abstract][Full Text] [Related]
2. Analysis of m6A RNA Methylation-Related Genes in Liver Hepatocellular Carcinoma and Their Correlation with Survival.
Li Y; Qi D; Zhu B; Ye X
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540684
[TBL] [Abstract][Full Text] [Related]
3. The functions and prognostic values of m6A RNA methylation regulators in thyroid carcinoma.
Yu ZH; Feng ST; Zhang D; Cao XC; Yu Y; Wang X
Cancer Cell Int; 2021 Jul; 21(1):385. PubMed ID: 34281544
[TBL] [Abstract][Full Text] [Related]
4. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
Qi LW; Jia JH; Jiang CH; Hu JM
Front Genet; 2020; 11():614566. PubMed ID: 33519919
[TBL] [Abstract][Full Text] [Related]
5. m6A RNA methylation regulators play an important role in the prognosis of patients with testicular germ cell tumor.
Cong R; Ji C; Zhang J; Zhang Q; Zhou X; Yao L; Luan J; Meng X; Song N
Transl Androl Urol; 2021 Feb; 10(2):662-679. PubMed ID: 33718069
[TBL] [Abstract][Full Text] [Related]
6. N6-Methyladenosine Regulators Promote Malignant Progression of Gastric Adenocarcinoma.
Zhao Y; Yan X; Wang Y; Zhou J; Yu Y
Front Oncol; 2021; 11():726018. PubMed ID: 35299934
[TBL] [Abstract][Full Text] [Related]
7. The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma.
Li F; Zhang P
Comput Math Methods Med; 2021; 2021():8715823. PubMed ID: 34840598
[TBL] [Abstract][Full Text] [Related]
8. Potential role of m6A RNA methylation regulators in osteosarcoma and its clinical prognostic value.
Liu H; Qin G; Ji Y; Wang X; Bao H; Guan X; Wei A; Cai Z
J Orthop Surg Res; 2021 May; 16(1):294. PubMed ID: 33952279
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
Front Genet; 2022; 13():872186. PubMed ID: 35937991
[No Abstract] [Full Text] [Related]
10. Identification of clinical prognostic features of esophageal cancer based on m6A regulators.
Wang H; Zhang Y; Chen L; Liu Y; Xu C; Jiang D; Song Q; Wang H; Wang L; Lin Y; Chen Y; Chen J; Xu Y; Hou Y
Front Immunol; 2022; 13():950365. PubMed ID: 36159855
[TBL] [Abstract][Full Text] [Related]
11. Construction of a risk prediction model using m6A RNA methylation regulators in prostate cancer: comprehensive bioinformatic analysis and histological validation.
Quan Y; Zhang X; Ping H
Cancer Cell Int; 2022 Jan; 22(1):33. PubMed ID: 35045837
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive analysis of m6A regulators prognostic value in prostate cancer.
Ji G; Huang C; He S; Gong Y; Song G; Li X; Zhou L
Aging (Albany NY); 2020 Jul; 12(14):14863-14884. PubMed ID: 32710725
[TBL] [Abstract][Full Text] [Related]
13. Construction and Validation of an m6A RNA Methylation Regulators-Based Prognostic Signature for Esophageal Cancer.
Xu LC; Pan JX; Pan HD
Cancer Manag Res; 2020; 12():5385-5394. PubMed ID: 32753956
[TBL] [Abstract][Full Text] [Related]
14. Construction and validation of an m6A RNA methylation regulator prognostic model for early-stage clear cell renal cell carcinoma.
Wang Z; Zhang M; Seery S; Zheng G; Wang W; Zhao Y; Wang X; Zhang Y
Oncol Lett; 2022 Aug; 24(2):250. PubMed ID: 35761938
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
16. Differential analysis of RNA methylation regulators in gastric cancer based on TCGA data set and construction of a prognostic model.
Li J; Zuo Z; Lai S; Zheng Z; Liu B; Wei Y; Han T
J Gastrointest Oncol; 2021 Aug; 12(4):1384-1397. PubMed ID: 34532096
[TBL] [Abstract][Full Text] [Related]
17. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Fang Q; Chen H
Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
[TBL] [Abstract][Full Text] [Related]
18. The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma.
Liu T; Li C; Jin L; Li C; Wang L
Med Sci Monit; 2019 Dec; 25():9435-9445. PubMed ID: 31823961
[TBL] [Abstract][Full Text] [Related]
19. Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma.
Zhang Y; Li L; Ye Z; Zhang L; Yao N; Gai L
Ann Transl Med; 2021 Oct; 9(20):1554. PubMed ID: 34790760
[TBL] [Abstract][Full Text] [Related]
20. Expressions of m6A RNA methylation regulators and their clinical predictive value in cervical squamous cell carcinoma and endometrial adenocarcinoma.
Wu H; Dong H; Fu Y; Tang Y; Dai M; Chen Y; Wang G; Wu Y
Clin Exp Pharmacol Physiol; 2021 Feb; 48(2):270-278. PubMed ID: 33006785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
